LIPELLA PHARMACEUTICALS INC.

Lipella Pharmaceuticals Inc.

Biotechnology • Healthcare • Pittsburgh, PA, United States • LIPO (PNK)

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

412 894 1853 7800 Susquehanna St., Pittsburgh, PA 15208, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market - GlobeNewswire
GlobeNewswire • Jun 20
Lipella stock tumbles after Nasdaq delisting over rule violations - Investing.com
Investing.com • Jun 20
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $3,788,000 Private Placement - Yahoo Finance
Yahoo Finance • Mar 4
Lipella Pharmaceuticals(NASDAQ:LIPO) Faces Decline in Biotech Sector Nasdaq Composite - Kalkine Media
Kalkine Media • Jun 20
Lipella Pharmaceuticals delisted from Nasdaq, explores relisting options amid ongoing operations - The Business Journals
The Business Journals • Jun 26

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has LIPELLA PHARMACEUTICALS INC. had layoffs?
No layoff events have been recorded for LIPELLA PHARMACEUTICALS INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does LIPELLA PHARMACEUTICALS INC. have?
LIPELLA PHARMACEUTICALS INC. has approximately 5 employees.
What industry is LIPELLA PHARMACEUTICALS INC. in?
LIPELLA PHARMACEUTICALS INC. operates in the Biotechnology industry, within the Healthcare sector.
Is LIPELLA PHARMACEUTICALS INC. a publicly traded company?
Yes, LIPELLA PHARMACEUTICALS INC. is publicly traded under the ticker symbol LIPO on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is LIPELLA PHARMACEUTICALS INC. headquartered?
LIPELLA PHARMACEUTICALS INC. is headquartered in Pittsburgh, PA, United States at 7800 Susquehanna St., Pittsburgh, PA 15208, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.